Related Experiment Video

Updated: Jun 6, 2026

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on: July 12, 2018

Glypican-3: a new target for cancer immunotherapy

Mitchell Ho1, Heungnam Kim

  • 1Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4264, USA. homi@mail.nih.gov

European Journal of Cancer (Oxford, England : 1990)
|November 30, 2010
PubMed

Insights

Glypican-3 (GPC3) is over-expressed in hepatocellular carcinoma (HCC), making it a promising target for immunotherapy. Research into GPC3 offers new therapeutic avenues for liver cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunotherapy

Background:

  • Hepatocellular carcinoma (HCC) is a prevalent global malignancy.
  • Novel molecular targets are crucial for advancing HCC therapeutics.
  • Glypican-3 (GPC3) is a cell-surface protein implicated in cancer biology.

Purpose of the Study:

  • To review the structure, function, and biology of GPC3.
  • To evaluate GPC3's potential as a therapeutic target for HCC immunotherapy.
  • To discuss GPC3's role in cancer and its utility as a biomarker.

Main Methods:

  • Literature review focusing on GPC3's molecular characteristics.
  • Analysis of GPC3's interaction with signaling pathways (Wnt, Hedgehog).
  • Examination of GPC3 expression in HCC and its association with Simpson-Golabi-Behmel syndrome (SGBS).

Main Results:

  • GPC3 is significantly over-expressed in HCC tissues.
  • GPC3 interacts with key growth factor signaling pathways.
  • An anti-GPC3 antibody demonstrates anti-cancer effects in preclinical models.

Conclusions:

  • GPC3 is a highly promising therapeutic target for HCC.
  • Immunotherapy targeting GPC3 is under clinical investigation.
  • Soluble GPC3 shows potential as a diagnostic biomarker for HCC.

More Related Videos

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...